Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Apomorphine nasal powder: Britannia will begin in July a dose-ranging U.K. Phase I trial in 6 healthy male volunteers.

Britannia Pharmaceuticals Ltd., London, U.K.
Product:

Read the full 63 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE